534 related articles for article (PubMed ID: 7806025)
1. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
[TBL] [Abstract][Full Text] [Related]
2. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group.
Ilonen J; Merivuori H; Reijonen H; Knip M; Akerblom HK; Pociot F; Nerup J
Scand J Immunol; 1992 Dec; 36(6):779-83. PubMed ID: 1361076
[TBL] [Abstract][Full Text] [Related]
4. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
[TBL] [Abstract][Full Text] [Related]
5. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. DiMe Study Group. Childhood Diabetes in Finland.
Langholz B; Tuomilehto-Wolf E; Thomas D; Pitkäniemi J; Tuomilehto J
Genet Epidemiol; 1995; 12(5):441-53. PubMed ID: 8557177
[TBL] [Abstract][Full Text] [Related]
6. Is the high incidence of diabetes in young children diagnosed under the age of 4 years determined by genetic factors in Finland? The DIME Study Group.
Tuomilehto-Wolf E; Tuomilehto J
Diabete Metab; 1993; 19(1 Pt 2):167-72. PubMed ID: 8314421
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
[TBL] [Abstract][Full Text] [Related]
8. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: II. Haplotype effects. DiMe Study Group. Childhood Diabetes in Finland.
Thomas D; Pitkäniemi J; Langholz B; Tuomilehto-Wolf E; Tuomilehto J
Genet Epidemiol; 1995; 12(5):455-66. PubMed ID: 8557178
[TBL] [Abstract][Full Text] [Related]
9. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
10. HLA five-locus haplotypes in Finns.
Ikäheimo I; Silvennoinen-Kassinen S; Tiilikainen A
Eur J Immunogenet; 1996 Aug; 23(4):321-8. PubMed ID: 8858288
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR4 subtype and -B alleles in DQB1*0302-positive haplotypes associated with IDDM. The Childhood Diabetes in Finland Study Group.
Reijonen H; Nejentsev S; Tuokko J; Koskinen S; Tuomilehto-Wolf E; Akerblom HK; Ilonen J
Eur J Immunogenet; 1997 Oct; 24(5):357-63. PubMed ID: 9442803
[TBL] [Abstract][Full Text] [Related]
12. New susceptibility haplotype for type 1 diabetes. DIME Study Group.
Tuomilehto-Wolf E; Tuomilehto J; Cepaitis Z; Lounamaa R
Lancet; 1989 Aug; 2(8658):299-302. PubMed ID: 2569104
[TBL] [Abstract][Full Text] [Related]
13. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
14. Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population.
Buyse I; Sandkuyl LA; Zamani Ghabanbasani M; Gu XX; Bouillon R; Bex M; Dooms L; Emonds MP; Duhamel M; Marynen P
Diabetologia; 1994 Aug; 37(8):808-17. PubMed ID: 7988783
[TBL] [Abstract][Full Text] [Related]
15. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
16. HLA alleles and IDDM in children in Hungary: a comparison with Finland.
Hermann R; Mijovic CH; Rayner M; Croft N; Kelly MA; Jenkins D; Soltész G; Barnett AH
Hum Immunol; 2001 Apr; 62(4):391-8. PubMed ID: 11295472
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a german population.
Badenhoop K; Donner H; Pani M; Rau H; Siegmund T; Braun J
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S89-92. PubMed ID: 10522814
[TBL] [Abstract][Full Text] [Related]
18. HLA-A associations with IDDM--a case of numbers?
Bonifacio E
Diabetologia; 1995 Jun; 38(6):751-2. PubMed ID: 7672503
[No Abstract] [Full Text] [Related]
19. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus.
Sanjeevi CB; Landin-Olsson M; Kockum I; Dahlquist G; Lernmark A
Tissue Antigens; 1995 Feb; 45(2):148-52. PubMed ID: 7792764
[TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
